PPIA
Basic information
Region (hg38): 7:44796680-44824564
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPIA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 1 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 1 | 0 | 0 |
Variants in PPIA
This is a list of pathogenic ClinVar variants found in the PPIA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-44801307-T-G | not specified | Uncertain significance (Aug 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PPIA | protein_coding | protein_coding | ENST00000468812 | 5 | 27885 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.557 | 0.431 | 125737 | 0 | 3 | 125740 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.99 | 41 | 95.8 | 0.428 | 0.00000476 | 1103 |
Missense in Polyphen | 0 | 7.8066 | 0 | 134 | ||
Synonymous | -0.00226 | 34 | 34.0 | 1.00 | 0.00000163 | 302 |
Loss of Function | 2.03 | 1 | 6.65 | 0.150 | 2.78e-7 | 88 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000472 | 0.0000462 |
European (Non-Finnish) | 0.0000178 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. {ECO:0000269|PubMed:20676357}.;
- Pathway
- Necroptosis - Homo sapiens (human);Tacrolimus/Cyclosporine Pathway, Pharmacodynamics;Prolactin Signaling Pathway;JAK-STAT;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Neutrophil degranulation;Disease;il-2 receptor beta chain in t cell activation;Prolactin;Minus-strand DNA synthesis;Assembly Of The HIV Virion;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Life Cycle;Host Interactions of HIV factors;HIV Infection;Plus-strand DNA synthesis;Infectious disease;Innate Immune System;Immune System;Binding and entry of HIV virion;APOBEC3G mediated resistance to HIV-1 infection;Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Cell surface interactions at the vascular wall;Hemostasis;Basigin interactions;Uncoating of the HIV Virion;Reverse Transcription of HIV RNA;Integration of provirus;Early Phase of HIV Life Cycle
(Consensus)
Recessive Scores
- pRec
- 0.413
Intolerance Scores
- loftool
- 0.296
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58
Haploinsufficiency Scores
- pHI
- 0.164
- hipred
- Y
- hipred_score
- 0.556
- ghis
- 0.702
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.980
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Low | Low |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ppia
- Phenotype
- homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; liver/biliary system phenotype; immune system phenotype; vision/eye phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- protein peptidyl-prolyl isomerization;RNA-dependent DNA biosynthetic process;protein folding;viral life cycle;uncoating of virus;fusion of virus membrane with host plasma membrane;virion assembly;viral release from host cell;entry into host cell;lipid droplet organization;interleukin-12-mediated signaling pathway;protein refolding;neutrophil degranulation;regulation of viral genome replication;positive regulation of viral genome replication;positive regulation of protein secretion;leukocyte migration;establishment of integrated proviral latency
- Cellular component
- extracellular region;extracellular space;nucleus;cytosol;focal adhesion;membrane;vesicle;protein-containing complex;secretory granule lumen;extracellular exosome;ficolin-1-rich granule lumen
- Molecular function
- RNA binding;peptidyl-prolyl cis-trans isomerase activity;protein binding;cyclosporin A binding;virion binding;unfolded protein binding